168 related articles for article (PubMed ID: 30735894)
21. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
22. Prolonged Dye Release from Mesoporous Silica-Based Imaging Probes Facilitates Long-Term Optical Tracking of Cell Populations In Vivo.
Rosenholm JM; Gulin-Sarfraz T; Mamaeva V; Niemi R; Özliseli E; Desai D; Antfolk D; von Haartman E; Lindberg D; Prabhakar N; Näreoja T; Sahlgren C
Small; 2016 Mar; 12(12):1578-92. PubMed ID: 26807551
[TBL] [Abstract][Full Text] [Related]
23. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.
Keliher EJ; Ye YX; Wojtkiewicz GR; Aguirre AD; Tricot B; Senders ML; Groenen H; Fay F; Perez-Medina C; Calcagno C; Carlucci G; Reiner T; Sun Y; Courties G; Iwamoto Y; Kim HY; Wang C; Chen JW; Swirski FK; Wey HY; Hooker J; Fayad ZA; Mulder WJ; Weissleder R; Nahrendorf M
Nat Commun; 2017 Jan; 8():14064. PubMed ID: 28091604
[TBL] [Abstract][Full Text] [Related]
24. Copper-free click chemistry with the short-lived positron emitter fluorine-18.
Bouvet V; Wuest M; Wuest F
Org Biomol Chem; 2011 Nov; 9(21):7393-9. PubMed ID: 21938294
[TBL] [Abstract][Full Text] [Related]
25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
26. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of Spirotetramat Transfer in Cucumber Plant Using Mesoporous Silica Nanoparticles as Carriers.
Zhao P; Yuan W; Xu C; Li F; Cao L; Huang Q
J Agric Food Chem; 2018 Nov; 66(44):11592-11600. PubMed ID: 30350969
[TBL] [Abstract][Full Text] [Related]
28. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
29. Cell labeling and tracking method without distorted signals by phagocytosis of macrophages.
Kang SW; Lee S; Na JH; Yoon HI; Lee DE; Koo H; Cho YW; Kim SH; Jeong SY; Kwon IC; Choi K; Kim K
Theranostics; 2014; 4(4):420-31. PubMed ID: 24578725
[TBL] [Abstract][Full Text] [Related]
30. Novel fluorine-18 labeled 5-(1-pyrrolidinylsulfonyl)-7-azaisatin derivatives as potential PET tracers for in vivo imaging of activated caspases in apoptosis.
Waldmann CM; Hermann S; Faust A; Riemann B; Schober O; Schäfers M; Haufe G; Kopka K
Bioorg Med Chem; 2015 Sep; 23(17):5734-9. PubMed ID: 26210158
[TBL] [Abstract][Full Text] [Related]
31. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
[TBL] [Abstract][Full Text] [Related]
32. The efficiency of
Wang M; McNitt CD; Wang H; Ma X; Scarry SM; Wu Z; Popik VV; Li Z
Chem Commun (Camb); 2018 Jul; 54(56):7810-7813. PubMed ID: 29946609
[TBL] [Abstract][Full Text] [Related]
33. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for
Zettlitz KA; Waldmann CM; Tsai WK; Tavaré R; Collins J; Murphy JM; Wu AM
J Nucl Med; 2019 Oct; 60(10):1467-1473. PubMed ID: 30877181
[TBL] [Abstract][Full Text] [Related]
34. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
35. Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry.
Hou S; Choi JS; Garcia MA; Xing Y; Chen KJ; Chen YM; Jiang ZK; Ro T; Wu L; Stout DB; Tomlinson JS; Wang H; Chen K; Tseng HR; Lin WY
ACS Nano; 2016 Jan; 10(1):1417-24. PubMed ID: 26731174
[TBL] [Abstract][Full Text] [Related]
36. Functional mesoporous silica nanoparticles for bio-imaging applications.
Cha BG; Kim J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1515. PubMed ID: 29566308
[TBL] [Abstract][Full Text] [Related]
37. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
38. Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node.
Sun Y; Yu M; Liang S; Zhang Y; Li C; Mou T; Yang W; Zhang X; Li B; Huang C; Li F
Biomaterials; 2011 Apr; 32(11):2999-3007. PubMed ID: 21295345
[TBL] [Abstract][Full Text] [Related]
39. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
He Q; Zhang Z; Gao F; Li Y; Shi J
Small; 2011 Jan; 7(2):271-80. PubMed ID: 21213393
[TBL] [Abstract][Full Text] [Related]
40. The Bioimaging Applications of Mesoporous Silica Nanoparticles.
Pratiwi FW; Kuo CW; Wu SH; Chen YP; Mou CY; Chen P
Enzymes; 2018; 43():123-153. PubMed ID: 30244805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
